Advanced search
Publication Cover
Research and Reports in Urology Volume 12, 2020 - Issue
Submit an article Journal homepage
194
Views
2
CrossRef citations to date
0
Altmetric
Review

Focus on Silodosin: Pros and Cons of Uroselectivity

Gianluigi Califano1 Department of Neurosciences, Reproductive Sciences and Odontostomatology – Federico II University of Naples, Naples, Italy
,
Claudia Collà Ruvolo1 Department of Neurosciences, Reproductive Sciences and Odontostomatology – Federico II University of Naples, Naples, ItalyORCID Iconhttps://orcid.org/0000-0001-8110-7341
ORCID Icon,
Massimiliano Creta1 Department of Neurosciences, Reproductive Sciences and Odontostomatology – Federico II University of Naples, Naples, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2082-3330
ORCID Icon,
Marco Capece1 Department of Neurosciences, Reproductive Sciences and Odontostomatology – Federico II University of Naples, Naples, ItalyORCID Iconhttps://orcid.org/0000-0002-1951-404X
ORCID Icon,
Roberto La Rocca1 Department of Neurosciences, Reproductive Sciences and Odontostomatology – Federico II University of Naples, Naples, Italy
,
Giuseppe Celentano1 Department of Neurosciences, Reproductive Sciences and Odontostomatology – Federico II University of Naples, Naples, Italy
,
Luigi Napolitano1 Department of Neurosciences, Reproductive Sciences and Odontostomatology – Federico II University of Naples, Naples, ItalyORCID Iconhttps://orcid.org/0000-0003-2036-0356
ORCID Icon,
Francesco Paolo Calace1 Department of Neurosciences, Reproductive Sciences and Odontostomatology – Federico II University of Naples, Naples, Italy
,
Gianluca Spena1 Department of Neurosciences, Reproductive Sciences and Odontostomatology – Federico II University of Naples, Naples, ItalyORCID Iconhttps://orcid.org/0000-0002-6714-9315
ORCID Icon,
Francesco Trama1 Department of Neurosciences, Reproductive Sciences and Odontostomatology – Federico II University of Naples, Naples, ItalyORCID Iconhttps://orcid.org/0000-0001-9291-2426
ORCID Icon,
Felice Crocetto1 Department of Neurosciences, Reproductive Sciences and Odontostomatology – Federico II University of Naples, Naples, Italy
,
Francesco Mangiapia1 Department of Neurosciences, Reproductive Sciences and Odontostomatology – Federico II University of Naples, Naples, Italy
,
Nicola Longo1 Department of Neurosciences, Reproductive Sciences and Odontostomatology – Federico II University of Naples, Naples, Italy
&
Ferdinando Fusco2 Department of Urology, Luigi Vanvitelli University of Naples, Naples, ItalyORCID Iconhttps://orcid.org/0000-0002-5158-5526
ORCID Icon show all
Pages 669-672 | Published online: 23 Dec 2020

References

  • Creta M, Bottone F, Sannino S, et al. Effects of alpha1-blockers on urodynamic parameters of bladder outlet obstruction in patients with lower urinary tract symptoms suggestive of benign prostatic enlargement: a review. Minerva Urol Nefrol. 2015.
  • Osman NI, Chapple CR, Cruz F, Desgrandchamps F, Llorente C, Montorsi F. Silodosin: a new subtype selective alpha-1 antagonist for the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia. Expert Opin Pharmacother. 2012;13(14):2085–2096. doi:10.1517/14656566.2012.71436822924980
  • Fusco F, Creta M, De Nunzio C, et al. Progressive bladder remodeling due to bladder outlet obstruction: a systematic review of morphological and molecular evidences in humans. BMC Urol. 2018;18(1):15. doi:10.1186/s12894-018-0329-429519236
  • Korstanje C, Krauwinkel W, van Doesum-wolters FL. Tamsulosin shows a higher unbound drug fraction in human prostate than in plasma: a basis for uroselectivity? Br J Clin Pharmacol. 2011;72(2):218–225. doi:10.1111/j.1365-2125.2010.03870.x21745239
  • Gratzke C, Bachmann A, Descazeaud A, et al. EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2015;67(6):1099–1109. doi:10.1016/j.eururo.2014.12.03825613154
  • Fusco F, Palmieri A, Ficarra V, et al. α1-blockers improve benign prostatic obstruction in men with lower urinary tract symptoms: a systematic review and meta-analysis of urodynamic studies. Eur Urol. 2016;69(6):1091–1101. doi:10.1016/j.eururo.2015.12.03426831507
  • Fusco F, Creta M, Imperatore V, et al. Benign prostatic obstruction relief in patients with lower urinary tract symptoms suggestive of benign prostatic enlargement undergoing endoscopic surgical procedures or therapy with alpha-blockers: a review of urodynamic studies. Adv Ther. 2017;34(4):773–783. doi:10.1007/s12325-017-0504-028255867
  • Oelke M, Bachmann A, Descazeaud A, et al. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2013;64(1):118–140. doi:10.1016/j.eururo.2013.03.00423541338
  • Fusco F, Creta M, Longo N, Persico F, Franco M, Mirone V. Silodosin 8 mg improves benign prostatic obstruction in Caucasian patients with lower urinary tract symptoms suggestive of benign prostatic enlargement: results from an explorative clinical study. BMC Urol. 2018;18(1):12. doi:10.1186/s12894-018-0326-729502524
  • Roehrborn CG, Kaplan SA, Lepor H, Volinn W. Symptomatic and urodynamic responses in patients with reduced or no seminal emission during silodosin treatment for LUTS and BPH. Prostate Cancer Prostatic Dis. 2011;14(2):143–148. doi:10.1038/pcan.2010.4621135869
  • Chapple CR, Montorsi F, Tammela TL, Wirth M, Koldewijn E, Fernández Fernández E. Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe. Eur Urol. 2011;59(3):342–352. doi:10.1016/j.eururo.2010.10.04621109344
  • Homma Y, Kawabe K, Takeda M, Yoshida M. Ejaculation disorder is associated with increased efficacy of silodosin for benign prostatic hyperplasia. Urology. 2010;76(6):1446–1450. doi:10.1016/j.urology.2010.03.01520472263
  • Gacci M, Ficarra V, Sebastianelli A, et al. Impact of medical treatments for male lower urinary tract symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review and meta-analysis. J Sex Med. 2014;11(6):1554–1566. doi:10.1111/jsm.1252524708055
  • Capitanio U, Salonia A, Briganti A, Montorsi F. Silodosin in the management of lower urinary tract symptoms as a result of benign prostatic hyperplasia: who are the best candidates. Int J Clin Pract. 2013;67(6):544–551. doi:10.1111/ijcp.1213523409749
  • Novara G, Chapple CR, Montorsi F. A pooled analysis of individual patient data from registrational trials of silodosin in the treatment of non-neurogenic male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH). BJU Int. 2014;114(3):427–433. doi:10.1111/bju.1271224571313
  • Nickel JC, Sander S, Moon TD. A meta-analysis of the vascular-related safety profile and efficacy of alpha-adrenergic blockers for symptoms related to benign prostatic hyperplasia. Int J Clin Pract. 2008;62(10):1547–1559. doi:10.1111/j.1742-1241.2008.01880.x18822025
  • Welliver C, Butcher M, Potini Y, McVary KT. Impact of alpha blockers, 5-alpha reductase inhibitors and combination therapy on sexual function. Curr Urol Rep. 2014;15(10):441. doi:10.1007/s11934-014-0441-225118850

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.